Advertisement
UK markets open in 7 hours 33 minutes

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • CRUDE OIL

    79.24
    +0.25 (+0.32%)
     

  • GOLD FUTURES

    2,316.20
    -6.10 (-0.26%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • Bitcoin GBP

    48,740.04
    -1,135.06 (-2.28%)
     

  • CMC Crypto 200

    1,302.16
    +7.49 (+0.58%)
     

  • NASDAQ Composite

    16,302.76
    -29.80 (-0.18%)
     

  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

U.S. FDA panel backs Valeant psoriasis drug with risk management

Reuters - UK Focus

July 19 (Reuters) - Valeant Pharmaceuticals International (NYSE: VRX - news) Inc's experimental drug to treat the skin disorder psoriasis should be approved as long as certain measures are put in place to mitigate the risk of suicide, an advisory committee to the U.S (Other OTC: UBGXF - news) . Food and Drug Administration concluded on Tuesday.

The FDA is not obliged to follow the advice of its advisory committees but typically does so. (Reporting by Toni Clarke in Washington; Editing by Alan Crosby)